|
|
Saquinavir (Fortovase, Invirase) Research
- The GEMINI Study: Are Saquinavir + Ritonavir and Lopinavir/Ritonavir Twins? (November 16, 2006)
In 8th International Congress on Drug Therapy in HIV Infection
- Research From the 42nd ICAAC: Two PIs vs. Two PIs vs. Efavirenz (December 2002)
[Archived Article]
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Protease Inhibitors Compared: Studies Examine Dosing, Cholesterol Levels Among Patients Using Fortovase, Invirase (June/July 2002)
[Archived Article]
In Positive Living, from AIDS Project Los Angeles
- Saquinavir/Mini-Dose Ritonavir Highly Potent in Treatment-Naive Patients (March/April 2002)
[Archived Article]
In Body Positive, from Body Positive
- Garlic and Saquinavir Interactions (February 8, 2002)
[Archived Article]
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- Garlic Reduces Saquinavir Blood Levels 50%; May Affect Other Drugs (December 21, 2001)
[Archived Article]
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
- Once-Daily Atazanavir Plus Saquinavir Favorably Affects Total Cholesterol (TC) and Fasting Triglyceride (TG) Profiles in Patients Failing Prior PI Therapy (Trial AI424-009, Week 24) (December 18, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
- Garlic Supplements Can Impede HIV Medication (December 5, 2001)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- A Phase IV Randomized Open-Label Multicenter Trial to Evaluate Safety and Efficacy of Indinavir/Ritonavir (800/100 mg BID) vs. Saquinavir/Ritonavir (1,000/100 mg BID) in Adult HIV-1 Infection: The Max Cmin 1 Trial (October 29, 2001)
[Archived Article]
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO
- Minor Interaction Between Efavirenz and Saquinavir When Combined With Small Doses of Ritonavir in a QD Regimen (October 28, 2001)
[Archived Article]
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO
- Tolerability and Antiviral Activity of Fortovase Plus Ritonavir (May 2001)
[Archived Article]
In HEPP News, from Brown Medical School
- From Grapefruit Juice to Ritonavir (March 15, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- Adding Ritonavir to Boost Saquinavir (Spring 2001)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Garlic Supplements Decrease Saquinavir Plasma Concentrations (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Protease Inhibitor Boosting Enhances Saquinavir Therapy (January 2001)
[Archived Article]
Highlights from ICAAC 2000.
In Body Positive
- Randomized Salvage Therapy With Saquinavir-Ritonavir (SQV-RTV) Versus Saquinavir-Nelfinavir (SQV-NFV) for Highly Experienced HIV-Infected Patients (September 17, 2000)
[Archived Article]
In The 40th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Combining Amprenavir or Saquinavir With Efavirenz (Spring 2000)
[Archived Article]
Selected highlights from the 7th CROI.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Saquinavir and Ritonavir Dosing Should Not Be Staggered (Spring 2000)
[Archived Article]
Selected highlights from the 7th CROI.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Saquinavir Plus Ritonavir and Drugs Used to Reduce High Cholesterol (Spring 2000)
[Archived Article]
Selected highlights from the 7th CROI.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Phenotypic Resistance to Protease Inhibitors Predicts Outcome of a Five Drug Combination Including Ritonavir, Saquinavir and Efavirenz in Patients Who Failed on HAART (September 29, 1999)
[Archived Article]
In The 39th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- The Efficacy of Ritonavir (RTV)/Saquinavir (SQV) Antiretroviral Therapy (ART) in Patients Who Failed Nelfinavir (NFV): A Multi-Center Clinical Cohort Study (September 29, 1999)
[Archived Article]
In The 39th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Pharmakokinetic (PK) Interactions Between the HIV Protease Inhibitors Ritonavir (RTV) and Saquinavir (SQV) and VIAGRA (Sildenafil Citrate) (September 27, 1999)
[Archived Article]
In The 39th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- A Study in HIV Positive Women of Quadruple Therapy: Nelfinavir, Saquinavir, Stavudine, and Lamivudine (February 4, 1998)
[Archived Article]
From Seattle Treatment Education Project
- Safety of Saquinavir Soft Gelatin Capsule (SQV-SGC) With Other Antiviral Agents (September 28 - October 1, 1997)
[Archived Article]
In The 37th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Saquinavir Soft Gel Capsules Versus Indinavir as Part of AZT and 3TC Containing Triple Therapy (September 28-October 1, 1997)
[Archived Article]
In The 37th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Effects of Switching From Saquinavir Hard Capsule (SQV-HC) to Saquinavir Soft Gel Capsules (SQV-SGC) or Indinavir (IDV) (September 1997)
[Archived Article]
In The 35th Annual Meeting of the Infectious Diseases Society of America, from The Body PRO
- Roche Racks Up Millions in Early Saquinavir Sales While Unwitting Patients Prime Themselves for Protease X-Resistance (August 1997)
[Archived Article]
In TAGline, from Treatment Action Group
- Saquinavir: Major Study Shows Survival Benefit in Treatment-Naive Patients (July 4, 1997)
[Archived Article]
From AIDS Treatment News
- Ritonavir-Saquinavir Combination Therapy in Patients with Advanced HIV Infection (January 1997)
[Archived Article]
In The 4th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
|
Advertisement
|